USMLE® Step 3

Kaplan USMLE Step 3: Patient worries about developing dementia

UPDATED . 6 MIN READ

If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 3 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.  

Free study aid when you join the AMA

Medical students who become AMA members can select a free gift from a variety of powerful study aids for the USMLE and COMLEX-USA tests.

Supporting you today as a medical student. Protecting your future as a physician.

A 49-year-old woman with a history of bipolar disorder type I presents to the clinic with increased fatigue, forgetfulness and poor concentration in the past couple of weeks. She complains that it takes her forever to clean the house, and that she does not feel as efficient as usual. Her daughter criticizes her weight gain, even though the patient persistently denies increased appetite. She denies any recent mood swings, and reports being compliant with her medication.

She has been treated with lithium for the past 14 years. She worries that she is developing Alzheimer dementia because her paternal grandmother suffered from it. Her daughter is worried that her mother is getting depressed, even though this depression seems different from episodes she has had in the past. Her physical examination, aside from mild obesity and mild lower-extremity edema, is otherwise unremarkable.

Which of the following is the most appropriate next step?

A. Begin treatment with a selective serotonin reuptake inhibitor (SSRI).

B. Discontinue lithium.

C. Order a dexamethasone suppression test.

D. Order a thyroid-stimulating hormone (TSH) level.

E. Schedule a brain MRI.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The correct answer is D.

The most reasonable step in management of this patient is to order a serum TSH level. The symptoms she describes can be a consequence of hypothyroidism. Long-term lithium treatment can cause iatrogenic hypothyroidism.

Psychiatric manifestations of hypothyroidism include fatigue, depression, lethargy, psychomotor retardation, poor concentration, and forgetfulness. If a patient has been otherwise stable on lithium for years, there is no need to switch to another mood stabilizer. Instead, replacement therapy can be started with levothyroxine.

Choice A: An SSRI would need to be justified after ruling out other medical conditions which can present with depressive symptoms. Caution, too, about a possible lithium-SSRI interaction and lithium toxicity.

 

 

 

Did you answer the question correctly?

Log in to get tips to remember and learn more from Kaplan Medical about why the other answer choices can be eliminated.

AMA membership has its advantages

  • Access education programs and study guides to help you thrive.
  • Distinguish yourself with AMA leadership opportunities.
  • Enjoy exclusive perks and savings.

Not a member? Become a member now.

FEATURED STORIES FOR MEDICAL STUDENTS